全文获取类型
收费全文 | 1209篇 |
免费 | 65篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 31篇 |
妇产科学 | 75篇 |
基础医学 | 90篇 |
口腔科学 | 13篇 |
临床医学 | 121篇 |
内科学 | 200篇 |
皮肤病学 | 28篇 |
神经病学 | 30篇 |
特种医学 | 97篇 |
外科学 | 292篇 |
综合类 | 88篇 |
一般理论 | 2篇 |
预防医学 | 68篇 |
眼科学 | 19篇 |
药学 | 83篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 45篇 |
出版年
2014年 | 8篇 |
2012年 | 7篇 |
2011年 | 8篇 |
2010年 | 7篇 |
2009年 | 12篇 |
2008年 | 5篇 |
2007年 | 16篇 |
2006年 | 6篇 |
2001年 | 5篇 |
1999年 | 9篇 |
1998年 | 15篇 |
1997年 | 24篇 |
1996年 | 23篇 |
1995年 | 18篇 |
1994年 | 21篇 |
1993年 | 24篇 |
1992年 | 16篇 |
1991年 | 17篇 |
1990年 | 16篇 |
1989年 | 17篇 |
1988年 | 26篇 |
1987年 | 31篇 |
1986年 | 27篇 |
1985年 | 15篇 |
1984年 | 19篇 |
1983年 | 19篇 |
1982年 | 13篇 |
1981年 | 19篇 |
1980年 | 9篇 |
1979年 | 12篇 |
1978年 | 6篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1974年 | 7篇 |
1973年 | 5篇 |
1965年 | 6篇 |
1964年 | 5篇 |
1962年 | 8篇 |
1961年 | 8篇 |
1960年 | 9篇 |
1959年 | 67篇 |
1958年 | 103篇 |
1957年 | 103篇 |
1956年 | 101篇 |
1955年 | 103篇 |
1954年 | 92篇 |
1949年 | 55篇 |
1948年 | 56篇 |
1946年 | 8篇 |
排序方式: 共有1295条查询结果,搜索用时 281 毫秒
1.
Intratemporal vascular tumors: detection with CT and MR imaging 总被引:1,自引:0,他引:1
Lo WW; Shelton C; Waluch V; Solti-Bohman LG; Carberry JN; Brackmann DE; Wade CT 《Radiology》1989,171(2):445-448
The diagnostic contributions of computed tomography (CT) and magnetic resonance (MR) imaging were compared in 12 patients with benign intratemporal vascular tumors (hemangioma or vascular malformation). The tumors included six in the internal acoustic canal and six in the geniculate ganglion region. Clinical and histologic correlations were made. Two of the six patients with tumors in the internal acoustic canal underwent CT, and both required gas cisternography to show the tumor. Five patients in that group underwent MR imaging, and all five studies showed the tumor. All six patients with geniculate ganglion tumors underwent CT. Results in one study were questionable, and five showed the tumor. Five patients in this group underwent MR imaging, but the MR findings were positive in only two cases. MR imaging should therefore be performed before CT in the evaluation of facial nerve dysfunction, as it demonstrated all tumors in the internal acoustic canal and some in the geniculate ganglion region. If MR findings are negative, CT should then be performed to rule out a possible geniculate ganglion lesion. 相似文献
2.
ROD MOORE 《European journal of oral sciences》1991,99(3):229-235
Abstract – Two types of fear desensitization, video training, and clinical rehearsals, were evaluated using psychometric tests, behavioral measures, and interviews for a group of 68 dental fear patients with high and low general trait anxiety. After treatment, a visual analogue scale (VAS) also tested the degree of perceived anxiety before going off to an unknown dentist. Results indicated no significant differences in dental fear reduction effects of the two types of desensitization. However, both treatments showed significant and meaningful effects when compared with a group of 75 dental fear patients on a waiting list who were also tested once at the beginning of the waiting period and again after 6 months. Only high general anxiety subjects resisted desensitization and failed standardized dental treatment tests. Exit interviews revealed that both groups named securing/accepting personnel, conversations about their fears and relaxation, in that order, as the most important factors in their dental fear reduction. Psychometric trust scores confirmed this. VAS scores showed a significant increase in fear level about the next dentist, also indicating trust as a major factor in reducing dental fear. Suggestions are made about which patient conditions can affect the choice of either of these training methods. 相似文献
3.
4.
5.
6.
7.
Seong‐II BIN Shing‐Sheng WU Xiaofeng ZENG Alan MOORE Nicole FRANK 《International journal of rheumatic diseases》2007,10(3):190-197
Aim: The aim of the current study was to assess the efficacy, safety, and tolerability of lumiracoxib 200 mg once daily (o.d.) in relieving osteoarthritis (OA) knee pain in patients in China, Taiwan, and South Korea. Methods: Patients of either sex (aged ≥ 18 years) with symptomatic, primary OA of the knee for ≥ 3 months were eligible for inclusion if they had OA pain intensity of ≥ 40 mm (100 mm visual analogue scale [VAS]) in the target knee joint during the previous 24 h. Patients were required to undergo regular non‐steroidal anti‐inflammatory drug therapy for ≥ 6 weeks. After 3–7 days of screening, patients were randomized (1 : 1) to receive either lumiracoxib 200 mg o.d. or celecoxib 200 mg o.d. The primary efficacy comparison between the study groups was overall OA pain intensity (VAS) in the target knee after 6 weeks of treatment. Results: The mean overall OA pain intensity (VAS) in the target knee after 6 weeks decreased from 60.6 mm to 35.7 mm and 60.5 mm to 36.1 mm in the lumiracoxib and celecoxib groups, respectively. Both study groups showed similar results in terms of improvement in both patient's and physician's global assessment of disease activity and functional health status. The percentage of adverse events (AEs) in the lumiracoxib and celecoxib groups (40.3% and 37.9%, respectively) was similar, as was the proportion of treatment‐related AEs (21.0% and 18.2%, respectively). Conclusions: Lumiracoxib 200 mg o.d. provided effective and well‐tolerated pain relief similar to that achieved with celecoxib 200 mg o.d. in knee OA patients. 相似文献
8.
Ananthila ANANDACOOMARASAMY John MOORE Neil MCGILL Nicholas MANOLIOS Helen ENGLERT 《International journal of rheumatic diseases》2006,9(3):298-301
The use of haematopoietic stem cell transplantation (HSCT) has now expanded beyond the domain of haematological diseases. Increasingly, the benefits of intense immunosuppression in the management of severe autoimmune diseases are being recognized. In diffuse systemic sclerosis (SSc), there has been increasing evidence of the efficacy of HSCT in improving morbidity and mortality. We present the first Australian patient to undergo autologous HSCT for SSc and review the current literature in the use of HSCT in SSc. Remarkably, the patient had complete resolution of skin disease (modified Rodnan skin score 27/51–0/51), tenosynovitis, synovitis and myositis. 相似文献
9.
10.